Kenyan Health Patient Information Leaflet
Non-opioid analgesic / antipyretic
Therapeutic use is agent- and indication-specific within the class (Non-opioid analgesic / antipyretic). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Relief of symptoms of cold and flu.
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
[From component Chlorpheniramine] Drowsiness; psychomotor impairment; anti-muscarinic effects [e.g. urinary retention; dry mouth; GI disturbances; blurred vision]; allergic reactions; epileptic form seizure in patients with cerebral cortex focal lesion; muscle weakness; tachycardia; tight chest; paradoxical CNS stimulation - mostly in children.
Store as labelled. Keep out of reach of children.